IndieBio

IndieBio is an accelerator firm specializing in Synthetic Biology. The firm runs four month accelerator programs for both companies as well as teams with an idea. It prefers to invest in startups that are using biology as the basis of their technology and invests in seed, early stages too. The firm seeks to make investments in life science, biotechnology, and synthetic biology or around the field of Biotech and businesses that use biology to solve a problem and as the basis of their technology, spanning across processes, products, and software. It seeks to invest in ideas and startups based in any geography. The firm prefers to invest $250k through equity investment. It typically makes cash investment of $50k for exchange of eight percent equity in biotech startups and may receive more $25k as Convertible Loan Note if eligible. The firm prefers to invest in teams with two co-founders minimum rather than a single founder. IndieBio was founded in 2014 and is based in San Francisco, California with an additional office in New York, New York.

Past deals in Life Science

Capra Biosciences

Convertible Note in 2022
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.

RizLab Health

Convertible Note in 2021
Rizlab Health enables practitioners and patients to acquire full blood count readings in minutes. Founded in 2018 and is based in East Princeton.

Intrinsic Medicine

Convertible Note in 2021
Intrinsic Medicine is a venture-backed, virtual, clinical-stage company with a technical and operational platform built to efficiently and ethically bring important medicines to patients.

Wayfinder Biosciences

Seed Round in 2021
Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting small molecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA.

Nyoka Design Labs

Convertible Note in 2021
Nyoka Design Labs leverages advances in clean tech to build inspiring, earth-friendly innovations. Starting with the Nyoka Light Wand, a non-toxic glow stick powered with bioluminescence, to prevent the billion toxic, single-use plastic glow sticks that enter our environment every single year.

SEQUENTIAL

Pre Seed Round in 2021
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.

Biomage

Seed Round in 2020
Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

BrickBuilt Therapeutics

Seed Round in 2020
Microbiome-focused therapeutics for diseases of the oral cavity and their systemic effects

Stembionix

Convertible Note in 2020
Stembionix is a technology company that develops longevity products. The company's contact information is by mail and physical address.

Liberum Biotech

Pre Seed Round in 2020
Liberum offers next generation protein manufacturing. Taking advantage of our suite of proprietary molecular and hardware technologies, we bring speed, scalability and cost reduction to disrupt current biologics manufacturing practices. Our vision is to democratize access to the fruits of synthetic biology.

Stembionix

Pre Seed Round in 2019
Stembionix is a technology company that develops longevity products. The company's contact information is by mail and physical address.

Intrinsic Medicine

Seed Round in 2019
Intrinsic Medicine is a venture-backed, virtual, clinical-stage company with a technical and operational platform built to efficiently and ethically bring important medicines to patients.

Pando Nutrition

Seed Round in 2019
At Pando Nutrition, Inc. we are solving the antibiotic resistance crisis with genetically engineered probiotics that support livestock health and performance without the use of medically significant drugs.

Dahlia Biosciences

Convertible Note in 2019
Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

BiomeSense

Seed Round in 2019
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.

11 Biomics

Seed Round in 2019
11 Biomics is an early-stage, community-focused biotech company.

Dahlia Biosciences

Convertible Note in 2018
Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

Flore by Sun Genomics

Seed Round in 2017
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.

Scaled Biolabs

Seed Round in 2017
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.

Amino Labs

Seed Round in 2015
Amino Labs is a biotechnology company that aims to make genetic engineering accessible to everyone. It works to enable the next industrial revolution of personalized manufacturing using biology and help solve the world's biggest problem from fuel to food to medicine. Driven by ground-breaking technology and UX, Amino Labs' easy-to-use kits are giving rise to the next 99 million bioengineers, from the ages of 8 and up. The company was founded in 2015 and is based in Lethbridge, Canada.

Zymochem

Seed Round in 2015
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials without compromising price, performance, scale, or sustainability while minimizing CO2 loss during production. It also accelerates a real-zero economy by relieving carbon emissions in product development, use, and end-of-life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.